InsiderTrades.com logo
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
From Darwin   |   Ad
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
👉 Click here to access your FREE report now!
John M. Sparby net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

John Sparby Biography and Net Worth

COO of R1 RCM
John joined R1 in January 2004 and currently serves as the Executive Vice President, Chief Operating Officer. John is the operational leader of our revenue cycle customer engagements. Prior to this role, he served in various other positions including leader of the East region, leader of the Ascension Michigan Market, and other leadership roles in our Shared Service group. He brings extensive experience in all aspects of running modern revenue cycle operations.

Prior to joining R1, John spent seven years at Stockamp & Associates leading large-scale, end to end revenue cycle re-engineering projects for primarily academic health systems achieving 3%-4% in annual P&L benefit as well as significant balance sheet improvements. Prominent clients included NY Presbyterian, Continuum Health Partners of NY, University of Iowa Health System, UC San Diego Med Center, University of Colorado Health System. John received a Bachelor of Arts in Healthcare Administration and Political Science from Concordia College. He resides in Birmingham, Michigan.

What is John M. Sparby's net worth?

The estimated net worth of John M. Sparby is at least $3.81 million as of March 7th, 2024. Mr. Sparby owns 265,986 shares of R1 RCM stock worth more than $3,806,260 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Sparby may own. Additionally, Mr. Sparby receives a salary of $1,460,000.00 as COO at R1 RCM. Learn More about John M. Sparby's net worth.

How old is John M. Sparby?

Mr. Sparby is currently 48 years old. There are 4 older executives and no younger executives at R1 RCM. The oldest executive at R1 RCM is Mr. Lee Rivas, CEO & Director, who is 49 years old. Learn More on John M. Sparby's age.

What is John M. Sparby's salary?

As the COO of R1 RCM Inc., Mr. Sparby earns $1,460,000.00 per year. The highest earning executive at R1 RCM is Mr. Lee Rivas, CEO & Director, who commands a salary of $1,920,000.00 per year. Learn More on John M. Sparby's salary.

How do I contact John M. Sparby?

The corporate mailing address for Mr. Sparby and other R1 RCM executives is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. R1 RCM can also be reached via phone at (312) 324-7820 and via email at [email protected]. Learn More on John M. Sparby's contact information.

Has John M. Sparby been buying or selling shares of R1 RCM?

John M. Sparby has not been actively trading shares of R1 RCM during the last ninety days. Most recently, John M. Sparby sold 10,046 shares of the business's stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $14.33, for a transaction totalling $143,959.18. Following the completion of the sale, the president now directly owns 265,986 shares of the company's stock, valued at $3,811,579.38. Learn More on John M. Sparby's trading history.

Who are R1 RCM's active insiders?

R1 RCM's insider roster includes Richard Evans, Jr. (Insider), Michael Feiner (Director), Joseph Flanagan (CEO), John Henneman, III (Director), Gary Long (Insider), Alex Mandl (Director), Lee Rivas (CEO), and John Sparby (COO). Learn More on R1 RCM's active insiders.

Are insiders buying or selling shares of R1 RCM?

In the last year, insiders at the healthcare provider sold shares 1 times. They sold a total of 10,046 shares worth more than $143,959.18. The most recent insider tranaction occured on March, 7th when President John M Sparby sold 10,046 shares worth more than $143,959.18. Insiders at R1 RCM own 36.8% of the company. Learn More about insider trades at R1 RCM.

Information on this page was last updated on 3/7/2024.

John M. Sparby Insider Trading History at R1 RCM

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/7/2024Sell10,046$14.33$143,959.18265,986View SEC Filing Icon  
5/10/2023Sell20,000$16.36$327,200.00243,827View SEC Filing Icon  
8/19/2022Sell40,000$25.01$1,000,400.00123,772View SEC Filing Icon  
8/11/2022Sell4,365$26.03$113,620.95163,772View SEC Filing Icon  
8/9/2022Sell4,691$25.83$121,168.53188,137View SEC Filing Icon  
3/1/2021Sell34,367$28.31$972,929.77202,843View SEC Filing Icon  
2/26/2021Sell17,450$28.01$488,774.50202,843View SEC Filing Icon  
2/24/2021Sell30,000$28.66$859,800.00310,854View SEC Filing Icon  
2/22/2021Sell10,461$28.07$293,640.27310,854View SEC Filing Icon  
See Full Table

John M. Sparby Buying and Selling Activity at R1 RCM

This chart shows John M Sparby's buying and selling at R1 RCM by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

R1 RCM Company Overview

R1 RCM logo
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.
Read More

Today's Range

Now: $14.31
Low: $14.31
High: $14.31

50 Day Range

MA: $14.22
Low: $14.12
High: $14.31

2 Week Range

Now: $14.31
Low: $8.87
High: $15.12

Volume

N/A

Average Volume

3,231,958 shs

Market Capitalization

$6.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
From Darwin   |   Ad
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
👉 Click here to access your FREE report now!